Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| Cepheid, Medical Equipment, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| Cepheid, Medical Equipment Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| Cepheid, Medical Equipment, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| Cepheid, Medical Equipment, Deals By Market, 2010 to YTD 2016 | 9 | 1 |
| Cepheid, Medical Equipment, Deals Summary, 2010 to YTD 2016 | 10 | 2 |
| Cepheid, Medical Equipment, Deal Details | 12 | 26 |
| Partnerships | 12 | 1 |
| Cell Signaling Technology Enters Into Licensing Agreement With Cepheid For Personalized Cancer Diagnostics | 12 | 1 |
| Quidel Enters Into Licensing Agreement With Northwestern University And Northwestern Global Health Foundation | 13 | 1 |
| Novacyt Enters into Partnership with Cepheid | 14 | 1 |
| Cepheid Enters into Agreement with Foundation for Innovative New Diagnostics | 15 | 1 |
| Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers | 16 | 2 |
| Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK | 18 | 1 |
| Cepheid Enters Into Co-Development Agreement With Oregon Health and Science University | 19 | 1 |
| InGen BioSciences Enters Into Distribution Agreement With Quidel | 20 | 1 |
| InGen BioSciences Enters Into Distribution Agreement With Diagnostic Hybrids | 21 | 1 |
| Life Technologies Enters Into Co-Marketing Agreement With Quidel | 22 | 1 |
| Cepheid Enters Into Co-Development Agreement With FIND | 23 | 1 |
| Cepheid Enters Into Collaboration With Novartis | 24 | 1 |
| Cepheid Terminates Licensing Agreement With Roche | 25 | 1 |
| Equity Offering | 26 | 1 |
| Quidel Completes Underwritten Public Offering Of US$60 Million | 26 | 2 |
| Debt Offering | 28 | 1 |
| Quidel Prices Public Offering of 3.25% Senior Notes Due 2020 | 28 | 2 |
| Cepheid Completes Private Placement Of Notes Due 2021 For US$345 Million | 30 | 2 |
| Acquisition | 32 | 1 |
| Danaher to Acquire Cepheid | 32 | 2 |
| Quidel Acquires AnDiaTec, Molecular Diagnostics Company | 34 | 1 |
| Quidel Acquires BioHelix, Molecular Diagnostic Company, For US$10 Million | 35 | 1 |
| Quidel Completes Acquisition Of Diagnostic HYBRIDS | 36 | 2 |
| Cepheid - Key Competitors | 38 | 1 |
| Key Employees | 39 | 1 |
| Locations And Subsidiaries | 40 | 2 |
| Head Office | 40 | 1 |
| Other Locations &Subsidiaries | 40 | 2 |
| Recent Developments | 42 | 1 |
| Financial Announcements | 42 | 1 |
| Jul 28, 2016: Cepheid Reports Second Quarter 2016 Results | 42 | 1 |
| Apr 28, 2016: Cepheid Reports First Quarter 2016 Results | 43 | 1 |
| Feb 02, 2016: Cepheid Reports Fourth Quarter And Full Year 2015 Results | 44 | 1 |
| Oct 20, 2015: Cepheid Reports 2015 Third Quarter Results | 45 | 1 |
| Oct 13, 2015: Cepheid Reports Preliminary Results For 2015 Third Quarter | 46 | 1 |
| Jul 23, 2015: Cepheid Reports 2015 Second Quarter Results | 47 | 1 |
| Apr 23, 2015: Cepheid Reports 2015 First Quarter Results | 48 | 1 |
| Jan 29, 2015: Cepheid Reports Fourth Quarter And Full Year 2014 Results | 49 | 1 |
| Corporate Communications | 50 | 1 |
| Feb 10, 2016: Cepheid Announces Appointment of President and Chief Operating Officer and Welcomes Executive Vice President of Engineering and Operations | 50 | 1 |
| Apr 07, 2015: Cepheid Welcomes Executive Vice President And Chief Financial Officer | 51 | 1 |
| Legal and Regulatory | 52 | 1 |
| Jan 07, 2016: USAID And Cepheid Plan Collaboration To Accelerate Global Diagnosis Of Multidrug-Resistant Tuberculosis | 52 | 1 |
| Product News | 53 | 1 |
| Mar 09, 2016: Cepheid Announces First FDA-Cleared Test for Detection of Carbapenem Resistance Genes in Isolates of Multidrug Resistant 'Superbugs' | 53 | 1 |
| Dec 07, 2015: Cepheid Obtains FDA 510(k) Approval For Xpert Flu+RSV Xpress Test | 54 | 1 |
| Jul 29, 2015: 'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms | 55 | 1 |
| Jul 28, 2015: Cepheid Launches New Portable Molecular Diagnostics System At AACC | 56 | 1 |
| May 13, 2015: WHO Lists Cepheid's Xpert Ebola as Eligible for Procurement to Ebola Affected Countries | 57 | 1 |
| Apr 16, 2015: Cepheid And FIND's Xpert HIV-1 Qual Test Receives European Approval | 58 | 1 |
| Apr 15, 2015: Cepheid Announces European Approval of Xpert HCV Viral Load | 59 | 1 |
| Mar 24, 2015: Cepheid's Xpert Ebola Diagnostic Test Gets FDA Emergency Use Authorisation | 60 | 1 |
| Mar 24, 2015: On World TB Day 2015 Cepheid and NHLS Commemorate Global Shipment of the 10 Millionth Xpert MTB/RIF Test Cartridge | 61 | 1 |
| Feb 13, 2015: Cepheid Receives FDA Clearance for Expanded Claims on Tuberculosis Test | 62 | 1 |
| Product Approvals | 63 | 1 |
| Mar 09, 2016: Cepheid Announces First FDA-Cleared Test for Detection of Carbapenem Resistance Genes in Isolates of Multidrug Resistant 'Superbugs' | 63 | 1 |
| Dec 07, 2015: Cepheid Obtains FDA 510(k) Approval For Xpert Flu+RSV Xpress Test | 64 | 1 |
| Apr 16, 2015: Cepheid And FIND's Xpert HIV-1 Qual Test Receives European Approval | 65 | 1 |
| Apr 15, 2015: Cepheid Announces European Approval of Xpert HCV Viral Load | 66 | 1 |
| Mar 24, 2015: Cepheid's Xpert Ebola Diagnostic Test Gets FDA Emergency Use Authorisation | 67 | 1 |
| Feb 13, 2015: Cepheid Receives FDA Clearance for Expanded Claims on Tuberculosis Test | 68 | 1 |
| Other Significant Developments | 69 | 1 |
| Apr 21, 2016: Cepheid Announces Partner Distribution Agreement With Medline | 69 | 1 |
| Dec 01, 2015: Cepheid Reaffirms 2015 Outlook At Piper Jaffray Healthcare Conference | 70 | 1 |
| Jun 10, 2015: New Approach on HIV Viral Load Testing | 71 | 1 |
| Appendix | 72 | 1 |
| Methodology | 72 | 1 |
| About GlobalData | 72 | 1 |
| Contact Us | 72 | 1 |
| Disclaimer | 72 | 1 |